We then characterized the transcriptional changes in the developed primary tumors by NanoString nCounter PanCancer Pathways Panel and revealed a distinct separation between the SOX10+ and SOX10– tumors, indicating that their difference in transcriptional profile persisted over the course of tumor growth in vivo. This evidence concerns the gene SOX10 and neoplasm.